Suscribirse

Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20 years of clinical data - 09/12/25

Doi : 10.1016/j.acvd.2025.10.330 
Jonaz Font a, Charles Dolladille b, Damien Legallois a, Mayane Al Khoury a, Laure Champ-Rigot a, Corentin Chaumont c, Virginie Ferchaud a, Arnaud Pellissier a, Avi Sabbag d, e, Frédéric Anselme c, Paul Milliez a, Pierre Ollitrault a,
a Department of Cardiology, Caen University Hospital, Normandy University, UniCaen, 14000 Caen, France 
b Department of Pharmacology, Caen University Hospital, Normandy University, UniCaen, 14000 Caen, France 
c Department of Cardiology, Rouen University Hospital, 76031 Rouen, France 
d Leviev Heart Institute, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel 
e Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel 

Corresponding author. Department of Cardiology, Regional University Hospital, avenue de la Côte de Nacre, 14000 Caen, France. Department of Cardiology, Regional University Hospital avenue de la Côte de Nacre Caen 14000 France
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Tuesday 09 December 2025

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

AFCA efficacy has improved slightly since the description of PVI.
AFCA efficacy was based on the EHRA consensus criteria.
Efficacy improvement primarily attributable to advances in persistent AF treatment.
Gains in AFCA efficacy mainly observed up to 2010.
A ceiling effect in outcomes noted thereafter.
Findings highlight the need for a paradigm shift in AFCA strategies.
Comprehensive AF management approach needed to maintain sustained sinus rhythm.

El texto completo de este artículo está disponible en PDF.

Abstract

Early rhythm control has been shown to improve cardiovascular outcomes in patients with atrial fibrillation. Atrial fibrillation catheter ablation is a cornerstone of this strategy; however, the evolution of its efficacy over time remains unclear. This study aimed to evaluate temporal trends in atrial fibrillation catheter ablation efficacy over the past two decades. A systematic review was conducted using PubMed and the Cochrane Library, covering studies published between 01 January 2001 and 01 July 2023. Atrial fibrillation catheter ablation efficacy was defined as the absence of atrial arrhythmia recurrence (atrial fibrillation, atrial tachycardia and/or atrial flutter) at 12-month follow-up after a single ablation procedure, without the use of antiarrhythmic drugs. A random-effects meta-analysis of proportions was performed using a generalized linear mixed model. Meta-regression was employed to assess the impact of treatment year on ablation success. The study was registered in the PROSPERO registry: CRD42021258100. The analysis included 477 cohorts comprising 70,703 patients. The pooled estimate of atrial fibrillation catheter ablation efficacy was 66% (95% confidence interval 64% to 67%). A significant improvement in efficacy was observed over time (+1.09% per year; 95% confidence interval: 0.71% to 1.56%; P < 0.0001; R 2 = 7%). However, this improvement was primarily driven by early gains (before 2010) in patients with persistent atrial fibrillation. No evidence of publication bias was detected. This is the largest meta-analysis to date assessing temporal trends in atrial fibrillation catheter ablation efficacy. Although a modest, but statistically significant, improvement has occurred over the past two decades, progress has plateaued since 2010. These findings highlight the need for a paradigm shift in atrial fibrillation catheter ablation strategies, with a focus on improving lesion durability and integrating ablation within a comprehensive atrial fibrillation management approach aimed at sustained sinus rhythm maintenance.

El texto completo de este artículo está disponible en PDF.

Keywords : Atrial fibrillation, Catheter ablation, Outcome, Meta-analysis, Meta-regression


Esquema


© 2025  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.